Estados Unidos · Plataformas y datos · Finviz

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

Publicado por Finviz · Estados Unidos hace 3 d

WALTHAM, Mass.--(BUSINESS WIRE)--Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially…

Leer el artículo completo en Finviz Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (finviz.com)

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

También te puede interesar

Lower Fees, Higher Growth: Why Cost-Conscious Aerospace Investors May Favor XAR Over PPA

Genmab A/S (NASDAQ:GMAB) Stock Price Up 7.4% - What's Next?

SLB surges on strong Q3 results, upbeat 2027 outlook as Middle East rebounds

‘Some people did everything right’: I lost my home in the Great Recession. I rent in my 50s. Why is that judged as failure?

Jana Small Finance Bank Q2 FY27 slides: record profit drives guidance upgrade

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026

Compartir

También te puede interesar

Lower Fees, Higher Growth: Why Cost-Conscious Aerospace Investors May Favor XAR Over PPA

Genmab A/S (NASDAQ:GMAB) Stock Price Up 7.4% - What's Next?

SLB surges on strong Q3 results, upbeat 2027 outlook as Middle East rebounds

‘Some people did everything right’: I lost my home in the Great Recession. I rent in my 50s. Why is that judged as failure?

Jana Small Finance Bank Q2 FY27 slides: record profit drives guidance upgrade

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030